Intelligence · Clinical Pipeline

Sinovac Research and Pipeline

All ClinicalTrials.gov programs at Sinovac Research and — phase, modality, and trial IDs.

Programs: 37

Quick answer

Sinovac Research and has 37 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

36-71 months old children-experimental EV71 vaccine.

Sinovac Research and Development Co.,

Hand, Foot and Mouth Disease

phase 3 mab completed

1 trial
400U /0.5ml EV71 vaccine

Sinovac Research and Development Co.,

Hand, Foot and Mouth Disease

phase 3 mab completed

1 trial
Adsorbed COVID-19 (inactivated) Vaccine

Sinovac Research and Development Co.,

COVID-19

phase 3 mab completed

1 trial
COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

Sinovac Research and Development Co.,

COVID-19

phase 3 mab completed

1 trial
COVID-19 Vaccine,Inactivated

Sinovac Research and Development Co.,

COVID-19

phase 3 mab completed

1 trial
Experimental vaccine

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
Inactivated COVID-19 Vaccine

Sinovac Research and Development Co.,

COVID-19

phase 3 mab completed

4 trials
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Sinovac Research and Development Co.,

Seasonal Influenza

phase 3 mab completed

1 trial
Investigational live attenuated mumps vaccine

Sinovac Research and Development Co.,

Mumps

phase 3 mab completed

2 trials
Investigational sIPV

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
Investigational tetanus vaccine, adsorbed

Sinovac Research and Development Co.,

Tetanus

phase 3 mab completed

1 trial
Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

Sinovac Research and Development Co.,

Varicella

phase 3 mab active

1 trial
Medium-dosage COVID-19 Vaccine,Inactivated

Sinovac Research and Development Co.,

COVID-19

phase 3 mab terminated

1 trial
PROVARIX

Sinovac Research and Development Co.,

Varicella (Chickenpox)

phase 3 mab active

1 trial
Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

Sinovac Research and Development Co.,

Influenza

phase 3 mab active

1 trial
Quadrivalent influenza vaccine

Sinovac Research and Development Co.,

Seasonal Influenza

phase 3 mab completed

2 trials
Quadrivalent influenza vaccine(0.25ml)

Sinovac Research and Development Co.,

Seasonal Influenza

phase 3 mab completed

2 trials
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried

Sinovac Research and Development Co.,

Rabies

phase 3 mab active

2 trials
Rabies vaccine

Sinovac Research and Development Co.,

Rabies (Healthy Volunteers)

phase 3 mab active

1 trial
SARS-CoV-2 inactivated vaccine

Sinovac Research and Development Co.,

Covid19

phase 3 mab completed

1 trial
SARS-CoV-2 vaccine (inactivated)

Sinovac Research and Development Co.,

SARS-CoV2 Infection

phase 3 mab completed

1 trial
Sabin Strain Inactivated Poliovirus Vaccine

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
Sinovac PCV13

Sinovac Research and Development Co.,

Pneumococcal Infectious Diseases

phase 3 mab active

1 trial
Sinovac PCV13

Sinovac Research and Development Co.,

Pneumococcal Infectious Disease

phase 3 mab active

2 trials
Sinovac rabies vaccine

Sinovac Research and Development Co.,

Rabies (Healthy Volunteers)

phase 3 mab active

2 trials
Tetravalent influenza vaccine developed by Sinovac Biotech Co.

Sinovac Research and Development Co.,

Influenza

phase 3 small molecule active

1 trial
Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain

Sinovac Research and Development Co.,

COVID-19

phase 3 mab active

1 trial
Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14

Sinovac Research and Development Co.,

Covid19

phase 3 mab completed

1 trial
Vaccine manufactured at commercialized scale

Sinovac Research and Development Co.,

Varicella

phase 3 mab completed

1 trial
Varicella Vaccine

Sinovac Research and Development Co.,

Varicella

phase 3 mab completed

1 trial
Varicella Vaccine

Sinovac Research and Development Co.,

Varicella (Chickenpox)

phase 3 mab active

1 trial
bivalent enterovirus vaccine (Vero cell), inactivated

Sinovac Research and Development Co.,

Hand, Foot, and Mouth Disease（HFMD)

phase 3 mab active

1 trial
experimental vaccine

Sinovac Research and Development Co.,

Epidemic Meningitis

phase 3 mab active

4 trials
sIPV-bOPV-bOPV vaccination schedule

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
sIPV-sIPV-bOPV vaccination schedule

Sinovac Research and Development Co.,

Poliomyelitis

phase 3 mab completed

1 trial
three consecutive lots of EV71 vaccine

Sinovac Research and Development Co.,

Hand, Foot and Mouth Disease

phase 3 mab completed

1 trial

Frequently asked questions

How many pipeline programs does Sinovac Research and have?

37 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Quick answer

36-71 months old children-experimental EV71 vaccine.

400U /0.5ml EV71 vaccine

Adsorbed COVID-19 (inactivated) Vaccine

COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

COVID-19 Vaccine,Inactivated

Experimental vaccine

Inactivated COVID-19 Vaccine

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Investigational live attenuated mumps vaccine

Investigational sIPV

Investigational tetanus vaccine, adsorbed

Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

Medium-dosage COVID-19 Vaccine,Inactivated

PROVARIX

Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

Quadrivalent influenza vaccine

Quadrivalent influenza vaccine(0.25ml)

Rabies Vaccine (Serum-free Vero Cell), Freeze-dried

Rabies vaccine

SARS-CoV-2 inactivated vaccine

SARS-CoV-2 vaccine (inactivated)

Sabin Strain Inactivated Poliovirus Vaccine

Sinovac PCV13

Sinovac PCV13

Sinovac rabies vaccine

Tetravalent influenza vaccine developed by Sinovac Biotech Co.

Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain

Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14

Vaccine manufactured at commercialized scale

Varicella Vaccine

Varicella Vaccine

bivalent enterovirus vaccine (Vero cell), inactivated

experimental vaccine

sIPV-bOPV-bOPV vaccination schedule

sIPV-sIPV-bOPV vaccination schedule

three consecutive lots of EV71 vaccine

Frequently asked questions

Stay Ahead in Pharma